112 - Update on Novel Approaches to Antimicrobial Susceptibility Testing

Speaker(s)

• 

  Ritu Banerjee, MD, PhD

  Associate Professor
  Pediatric Infectious Diseases
  Vanderbilt University Medical Center
  Nashville, Tennessee

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Patricia Simner, PhD

  Associate Professor, Director of Bacteriology
  Johns Hopkins University School of Medicine
  Baltimore, Maryland

  Disclosure: Accelerate Diagnostics () : Consultant, Grant/Research Support; Affinity Biosensors () : Grant/Research Support; Ares-Genetics : Research Grant or Support (Status: Ongoing); BD Diagnostics, Inc () : Consultant, Grant/Research Support; CosmosID () : Grant/Research Support; GeneCapture : Consultant (Status: Ongoing); Hardy Diagnostics () : Grant/Research Support; IDbyDNA : Grant/Research Support (Status: Ongoing); OpGen () : Consultant, Grant/Research Support; Shionogi Inc : Consultant (Status: Ongoing)
• 

  Lars Westblade, PhD

  Associate Professor
  Pathology and Laboratory Medicine
  Weill Cornell Medicine
  New York, NY

  Disclosure: Accelerate Diagnostics, Inc. : Grant/Research Support (Status: Ongoing); BioFire Diagnostics, LLC : Grant/Research Support (Status: Ongoing); Hardy Diagnostics : Grant/Research Support (Status: Ongoing); Roche Molecular Systems, Inc. : Advisor or Review Panel member (Status: Ongoing), Grant/Research Support (Status: Ongoing); Shionogi, Inc. : Advisor or Review Panel member (Status: Terminated --- June 2, 2020)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-20-483-H04-P

Learning Objectives:

• describe the advantages and disadvantages of molecular resistance panels and their optimal implementation in the clinical microbiology laboratory
• discuss the status of applying WGS to predict antimicrobial resistance for clinical care
• describe novel technologies for rapid phenotypic antimicrobial susceptibility testing and their clinical impact

Presentations:

• 4:15pm – 5:30pm EDT

  Rapid Phenotypic Susceptibility Testing Assays
  Ritu Banerjee, MD, PhD – Vanderbilt University Medical Center
• 4:15pm – 5:30pm EDT

  Targeted Molecular Panels for Resistance Detection
  Lars Westblade, PhD – Weill Cornell Medicine
• 4:15pm – 5:30pm EDT

  Using Whole Genome Sequencing for Prediction of Antimicrobial Resistance
  Patricia J. Simner, PhD – Johns Hopkins University School of Medicine